captopril has been researched along with Osteolysis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abuohashish, HM; Ahmed, MM; Al-Rejaie, SS; Khattab, MM; Sabry, D | 1 |
| Cheng, T; Peng, X; Zhang, W; Zhang, X; Zhao, H | 1 |
2 other study(ies) available for captopril and Osteolysis
| Article | Year |
|---|---|
ACE-2/Ang1-7/Mas cascade mediates ACE inhibitor, captopril, protective effects in estrogen-deficient osteoporotic rats.
Topics: Administration, Oral; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Biomarkers; Bone and Bones; Bone Density Conservation Agents; Captopril; Delayed-Action Preparations; Female; Femur; Humans; Osteolysis; Osteoporosis, Postmenopausal; Ovariectomy; Peptide Fragments; Peptidyl-Dipeptidase A; Rats, Wistar; Receptors, G-Protein-Coupled; Signal Transduction; Spectrophotometry, Atomic; X-Ray Microtomography | 2017 |
Low-dose captopril inhibits wear debris-induced inflammatory osteolysis.
Topics: Animals; Base Sequence; Captopril; Cytokines; DNA Primers; Dose-Response Relationship, Drug; Female; Inflammation; Inflammation Mediators; Mice; Mice, Inbred BALB C; Osteolysis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Titanium | 2011 |